These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 433974)

  • 1. Regression of pituitary tumors, a possible effect of bromergocryptine.
    George SR; Burrow GN; Zinman B; Ezrin C
    Am J Med; 1979 Apr; 66(4):697-702. PubMed ID: 433974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macroprolactinoma resistant to bromocriptine].
    López-Espinosa E; Ayala AR; Grimaldo J; Kunhardt J; Villanueva C
    Arch Invest Med (Mex); 1989; 20(1):1-8. PubMed ID: 2669670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
    Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pregnancy on suspected pituitary adenomas after conservative management of ovulation defects associated with galactorrhea.
    Shewchuk AB; Adamson GD; Lessard P; Ezrin C
    Am J Obstet Gynecol; 1980 Mar; 136(5):659-66. PubMed ID: 7355945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Frantz AG; Kleinberg DL
    Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy despite continued elevation of prolactin levels while on bromergocryptine.
    Corson SL; Batzer FR
    Int J Gynaecol Obstet; 1985 Apr; 23(2):105-7. PubMed ID: 2862069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.
    Kleinberg DL; Noel GL; Frantz AG
    N Engl J Med; 1977 Mar; 296(11):589-600. PubMed ID: 840242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia: current concepts of management including medical therapy with bromocriptine.
    Thorner MO; Evans WS; MacLeod RM; Nunley WC; Rogol AD; Morris JL; Besser GM
    Adv Biochem Psychopharmacol; 1980; 23():165-89. PubMed ID: 7395611
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 15. Galactorrhea-amenorrhea syndromes: etiology and treatment.
    Spark RF; Pallotta J; Naftolin F; Clemens R
    Ann Intern Med; 1976 May; 84(5):532-7. PubMed ID: 945033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of prolactin-secreting pituitary tumors with bromocriptine].
    Katzir D; Rosenberg T; Ramot Y; Gaver-Shavit A; Gilboa Y
    Harefuah; 1990 Feb; 118(3):141-5. PubMed ID: 2341064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bromocriptine treatment of hyperprolactinemia].
    Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
    Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.